Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discovery

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100211Source: DataRank Database

Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discovery is a research paper published in SLAS DISCOVERY (2025). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.53)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Nadine Álvarez ORCID,Steven Park ORCID,Madhuvika Murugan ORCID,David S. Perlin ORCID,Abdeldjalil Madani

Live enrichment

PubMed:39824441 PMC:PMC13224317 OpenAlex:https://openalex.org/W4406389481

National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Grant: 1U19AI171401

National Institutes of Health

Grant: NR-54003

NIAID NIH HHS

Grant: U19 AI171401

National Institute of Allergy and Infectious Diseases

FWCI

1.53

Citation Percentile

0.8%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.slas-discovery.org/article/S2472-5552(25)00004-8/pdf

publisherhttps://www.slas-discovery.org/article/S2472-5552(25)00004-8/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2472555225000048?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555225000048?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.slasd.2025.100211

Fields of Study

Biosensors and Analytical DetectionSARS-CoV-2 detection and testingbioluminescence and chemiluminescence researchHumansAntiviral AgentsSARS-CoV-2High-Throughput Screening AssaysDrug DiscoveryA549 CellsDrug Evaluation, PreclinicalCOVID-19 Drug TreatmentCOVID-19Luminescent MeasurementsLuminescenceAngiotensin-Converting Enzyme 2

MeSH Terms

A549 CellsAngiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 Drug TreatmentAntiviral AgentsDrug Evaluation, PreclinicalHumansLuminescent MeasurementsLuminescenceDrug DiscoveryHigh-Throughput Screening Assays

Keywords

LuminescenceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Luminescent MeasurementsComputer scienceComputational biologyCoronavirus disease 2019 (COVID-19)MedicineBiologyOptoelectronicsMaterials scienceInternal medicineInfectious disease (medical specialty)DiseaseVirusesDrug screeningHTSAntiviralsNano-luciferaseSars-cov-2Bsl-3 VirusesMmv Global Health Priority Box

Rapid luminescence-based screening method for SARS- CoV-2 inhibitors discovery

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)